Importantly, several studies now link these local effects to systemic immunity—demonstrating dendritic cell activation, expansion of tumor-specific CD8+ T cells, and, in select settings, abscopal tumor control—thereby positioning nsPEFs as more than a local cytotoxic modality. This evidence concerns the gene CD8A and neoplasm.